New study sheds light on clotting risks in rare genetic disorder
NCT ID NCT03560570
First seen Mar 10, 2026 · Last updated May 22, 2026 · Updated 9 times
Summary
This study looked at how blood clots form in 57 people with Congenital Disorder of Glycosylation (CDG), a rare genetic condition. Researchers used a special test to measure clotting balance, aiming to understand if the body's natural clotting system stays stable despite known deficiencies. The goal was to better understand the disorder, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONGENITAL DISORDERS OF GLYCOSYLATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hôpital Necker Enfants malades
Paris, Paris, 75015, France
Conditions
Explore the condition pages connected to this study.